148 related articles for article (PubMed ID: 35494184)
1. High-dose-rate skin brachytherapy with interstitial, surface, or a combination of interstitial and surface mold technique.
Brovchuk S; Park SJ; Shepil Z; Romanenko S; Vaskevych O
J Contemp Brachytherapy; 2022 Apr; 14(2):107-114. PubMed ID: 35494184
[TBL] [Abstract][Full Text] [Related]
2. Non-melanoma skin cancer treated with high-dose-rate brachytherapy and Valencia applicator in elderly patients: a retrospective case series.
Delishaj D; Laliscia C; Manfredi B; Ursino S; Pasqualetti F; Lombardo E; Perrone F; Morganti R; Paiar F; Fabrini MG
J Contemp Brachytherapy; 2015 Dec; 7(6):437-44. PubMed ID: 26816500
[TBL] [Abstract][Full Text] [Related]
3. High-dose-rate brachytherapy in treatment of non-melanoma skin cancer of head and neck region: preliminary results of a prospective single institution study.
Kalaghchi B; Esmati E; Ghalehtaki R; Gomar M; Jaberi R; Gholami S; Babaloui S; Nabavi M; Sotoudeh S; Khanjani N; Kazemian A; Amouzegar-Hashemi F; Aghili M; Lashkari M
J Contemp Brachytherapy; 2018 Apr; 10(2):115-122. PubMed ID: 29789760
[TBL] [Abstract][Full Text] [Related]
4. Two different sizes of Valencia applicators in non-melanoma skin cancer treatment with iridium-192 high-dose-rate brachytherapy.
Laliscia C; Coccia N; Fuentes T; Perrone F; Paiar F
J Contemp Brachytherapy; 2021 Dec; 13(6):615-619. PubMed ID: 35079246
[TBL] [Abstract][Full Text] [Related]
5. High-dose-rate brachytherapy for non-melanoma skin cancer using tailored custom moulds - a single-centre experience.
Laliscia C; Fuentes T; Coccia N; Mattioni R; Perrone F; Paiar F
Contemp Oncol (Pozn); 2021; 25(1):12-16. PubMed ID: 33911976
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Basal Cell Carcinoma of the Lower Eyelid With High-Dose-Rate Brachytherapy.
Oliveira CN; Viveiros C; Travancinha C; Mota A; Pino I; Fonseca J; Madaleno T; Labareda M; Santos F; Esteves S
Cureus; 2024 Jan; 16(1):e53067. PubMed ID: 38410314
[TBL] [Abstract][Full Text] [Related]
7. Non-melanoma skin cancer treated with HDR Valencia applicator: clinical outcomes.
Tormo A; Celada F; Rodriguez S; Botella R; Ballesta A; Kasper M; Ouhib Z; Santos M; Perez-Calatayud J
J Contemp Brachytherapy; 2014 Jun; 6(2):167-72. PubMed ID: 25097557
[TBL] [Abstract][Full Text] [Related]
8. Clinical and cosmetic outcomes in patients treated with high-dose-rate electronic brachytherapy for nonmelanoma skin cancer.
Paravati AJ; Hawkins PG; Martin AN; Mansy G; Rahn DA; Advani SJ; Hoisak J; Dragojevic I; Martin PJ; Miller CJ; Sanghvi P
Pract Radiat Oncol; 2015; 5(6):e659-64. PubMed ID: 26432680
[TBL] [Abstract][Full Text] [Related]
9. High-dose-rate brachytherapy using Leipzig applicators for non-melanoma localized skin cancer.
Pellizzon ACA; Fogaroli R; Chen MJ; Maia P; Gondim G; Guedes DC; Ramos H; Silva MLG
J Contemp Brachytherapy; 2020 Oct; 12(5):435-440. PubMed ID: 33299432
[TBL] [Abstract][Full Text] [Related]
10. HDR brachytherapy for superficial non-melanoma skin cancers.
Gauden R; Pracy M; Avery AM; Hodgetts I; Gauden S
J Med Imaging Radiat Oncol; 2013 Apr; 57(2):212-7. PubMed ID: 23551783
[TBL] [Abstract][Full Text] [Related]
11. Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds.
Guix B; Finestres F; Tello J; Palma C; Martinez A; Guix J; Guix R
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):95-102. PubMed ID: 10758310
[TBL] [Abstract][Full Text] [Related]
12. Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of literature.
Delishaj D; Rembielak A; Manfredi B; Ursino S; Pasqualetti F; Laliscia C; Orlandi F; Morganti R; Fabrini MG; Paiar F
J Contemp Brachytherapy; 2016 Dec; 8(6):533-540. PubMed ID: 28115960
[TBL] [Abstract][Full Text] [Related]
13. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer.
Wazer DE; Berle L; Graham R; Chung M; Rothschild J; Graves T; Cady B; Ulin K; Ruthazer R; DiPetrillo TA
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):889-97. PubMed ID: 12095554
[TBL] [Abstract][Full Text] [Related]
14. Electronic brachytherapy for non-melanoma skin cancer in Asians: Experience from a Taiwan medical center.
Tang TY; Tang JY; Chu-Sung Hu S; Chiao-Li Ke K; Cheng ST
J Formos Med Assoc; 2022 Nov; 121(11):2317-2323. PubMed ID: 35570050
[TBL] [Abstract][Full Text] [Related]
15. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
[TBL] [Abstract][Full Text] [Related]
16. Interstitial high-dose-rate brachytherapy in eyelid cancer.
Mareco V; Bujor L; Abrunhosa-Branquinho AN; Ferreira MR; Ribeiro T; Vasconcelos AL; Ferreira CR; Jorge M
Brachytherapy; 2015; 14(4):554-64. PubMed ID: 25959364
[TBL] [Abstract][Full Text] [Related]
17. Custom mold applicator high-dose-rate brachytherapy for nonmelanoma skin cancer-An analysis of 273 lesions.
Olek D; El-Ghamry MN; Deb N; Thawani N; Shaver C; Mutyala S
Brachytherapy; 2018; 17(3):601-608. PubMed ID: 29398593
[TBL] [Abstract][Full Text] [Related]
18. High-dose-rate brachytherapy with surface applicator in penile cancer.
Saldi S; Zucchetti C; Fulcheri CPL; Saccia S; Alì E; Marani S; Ingrosso G; Aristei C
Brachytherapy; 2021; 20(4):835-841. PubMed ID: 33994341
[TBL] [Abstract][Full Text] [Related]
19. Computed tomography-based flap brachytherapy for non-melanoma skin cancers of the face.
Gogineni E; Cai H; Carillo D; Rana Z; Bloom B; Potters L; Gaballa H; Ghaly M
J Contemp Brachytherapy; 2021 Feb; 13(1):51-58. PubMed ID: 34025737
[TBL] [Abstract][Full Text] [Related]
20. High-dose-rate brachytherapy for localized penile cancer: Evolution of a technique.
Marbán M; Crook J; Keyes M; Dubash R; Batchelar D
Brachytherapy; 2020; 19(2):201-209. PubMed ID: 31959520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
